Shannon KM - Search Results

1

The Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in Huntington's disease.

Videnovic A, Bernard B, Fan W, Jaglin J, Leurgans S, Shannon KM. Videnovic A, et al. Among authors: shannon km. Mov Disord. 2010 Feb 15;25(3):401-4. doi: 10.1002/mds.22748. Mov Disord. 2010. PMID: 20108371

2

Daytime somnolence and nocturnal sleep disturbances in Huntington disease.

Videnovic A, Leurgans S, Fan W, Jaglin J, Shannon KM. Videnovic A, et al. Among authors: shannon km. Parkinsonism Relat Disord. 2009 Jul;15(6):471-4. doi: 10.1016/j.parkreldis.2008.10.002. Epub 2008 Nov 28. Parkinsonism Relat Disord. 2009. PMID: 19041273

3

Extensor truncal dystonia: successful treatment with botulinum toxin injections.

Comella CL, Shannon KM, Jaglin J. Comella CL, et al. Among authors: shannon km. Mov Disord. 1998 May;13(3):552-5. doi: 10.1002/mds.870130330. Mov Disord. 1998. PMID: 9613753 Clinical Trial.

4

Effect of donepezil on motor and cognitive function in Huntington disease.

Cubo E, Shannon KM, Tracy D, Jaglin JA, Bernard BA, Wuu J, Leurgans SE. Cubo E, et al. Among authors: shannon km. Neurology. 2006 Oct 10;67(7):1268-71. doi: 10.1212/01.wnl.0000238106.10423.00. Neurology. 2006. PMID: 17030764 Clinical Trial.

5

Suicidal ideation in Huntington disease: the role of comorbidity.

Wetzel HH, Gehl CR, Dellefave-Castillo L, Schiffman JF, Shannon KM, Paulsen JS; Huntington Study Group. Wetzel HH, et al. Among authors: shannon km. Psychiatry Res. 2011 Aug 15;188(3):372-6. doi: 10.1016/j.psychres.2011.05.006. Epub 2011 May 24. Psychiatry Res. 2011. PMID: 21605914 Free PMC article.

6

Impact of belief in neuroprotection on therapeutic intervention in Parkinson's disease.

Elble RJ, Suchowersky O, Shaftman S, Weiner WJ, Huang P, Tilley B; NINDS NET-PD Investigators. Elble RJ, et al. Mov Disord. 2010 Jun 15;25(8):1082-6. doi: 10.1002/mds.22997. Mov Disord. 2010. PMID: 20131372 Free PMC article.

7

Comorbidities of obsessive and compulsive symptoms in Huntington's disease.

Anderson KE, Gehl CR, Marder KS, Beglinger LJ, Paulsen JS; Huntington's Study Group. Anderson KE, et al. J Nerv Ment Dis. 2010 May;198(5):334-8. doi: 10.1097/NMD.0b013e3181da852a. J Nerv Ment Dis. 2010. PMID: 20458194 Free PMC article.

8

Diffusion tensor imaging of Parkinson's disease, atypical parkinsonism, and essential tremor.

Prodoehl J, Li H, Planetta PJ, Goetz CG, Shannon KM, Tangonan R, Comella CL, Simuni T, Zhou XJ, Leurgans S, Corcos DM, Vaillancourt DE. Prodoehl J, et al. Among authors: shannon km. Mov Disord. 2013 Nov;28(13):1816-22. doi: 10.1002/mds.25491. Epub 2013 May 14. Mov Disord. 2013. PMID: 23674400 Free PMC article.

9

Therapeutic advances in Huntington's Disease.

Shannon KM, Fraint A. Shannon KM, et al. Mov Disord. 2015 Sep 15;30(11):1539-46. doi: 10.1002/mds.26331. Epub 2015 Jul 30. Mov Disord. 2015. PMID: 26226924 Review.

10

Internal globus pallidotomy in dystonia secondary to Huntington's disease.

Cubo E, Shannon KM, Penn RD, Kroin JS. Cubo E, et al. Among authors: shannon km. Mov Disord. 2000 Nov;15(6):1248-51. doi: 10.1002/1531-8257(200011)15:6<1248::aid-mds1029>3.0.co;2-q. Mov Disord. 2000. PMID: 11104214

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

267 results

Search Page

Filters